Patent assignee · IE · COMPANY

Tibotec Pharmaceuticals Ltd.

68Patents
41Active
68Granted
47Portfolio score

Filing activity: Feb 14, 2002 → Jun 21, 2012 · 36 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7531548B2 HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines Chemistry; Metallurgy 55 Expired
US8022077B2 Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof Human Necessities 29 Expired
US8030318B2 Fused bicyclic inhibitors of HCV Human Necessities 28 Expired
US8148399B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 20 Active
US7700645B2 Pseudopolymorphic forms of a HIV protease inhibitor Human Necessities 19 Active
US8349869B2 Macrocylic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 12 Active
US7659245B2 Macrocylic inhibitors of hepatitis C virus Chemistry; Metallurgy 12 Active
US8153640B2 HIV inhibiting bicyclic pyrimdine derivatives Chemistry; Metallurgy 12 Active
US7442705B2 HIV replication inhibiting pyrimidines and triazines Chemistry; Metallurgy 11 Expired
US6649651B1 Hexahydrofuro[2,3-B]furan-3-yl-n{3[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor Human Necessities 9 Expired
US7989471B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 9 Active
US8153800B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 7 Active
US8012939B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 7 Active
US7199148B2 Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors Chemistry; Metallurgy 6 Expired
US7666834B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 6 Active
US7935710B2 Microbicidal pyrimidine or triazine for preventing sexual HIV transmission Human Necessities 6 Expired
US7449463B2 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication Chemistry; Metallurgy 4 Expired
US8426434B2 Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile Human Necessities 4 Active
US7465727B2 (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5-c][1,3]Benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors Human Necessities 3 Expired
US7157495B2 Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor Human Necessities 3 Expired
US8034835B2 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs Chemistry; Metallurgy 3 Active
US7126015B2 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol Emerging Cross-Sectional Technologies 3 Expired
US7217506B2 Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance Physics 3 Expired
US8036861B2 Method and means for determining the replication rate of a viral population Emerging Cross-Sectional Technologies 2 Active
US7087373B2 Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins Physics 2 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.